Lam Research (LRCX) Financials

$83.94 +2.88 (+3.55%)

Closing price 04:00 PM Eastern

Extended Trading

$83.92 -0.02 (-0.02%)

As of 07:23 PM Eastern

Annual Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/25/2023	6/26/2022	6/27/2021	6/28/2020	6/30/2019	6/24/2018	6/25/2017	6/26/2016	6/28/2015
Net Income / (Loss) Attributable to Common Shareholders	3,828	4,511	4,605	3,908	2,252	2,191	2,381	1,698	914	656
Consolidated Net Income / (Loss)	3,828	4,511	4,605	3,908	2,252	2,191	2,381	1,698	914	656
Net Income / (Loss) Continuing Operations	3,828	4,511	4,605	3,908	2,252	2,191	2,381	1,698	914	656
Total Pre-Tax Income	4,360	5,109	5,193	4,371	2,575	2,447	3,152	1,812	960	741
Total Operating Income	4,264	5,175	5,382	4,482	2,674	2,465	3,213	1,902	1,074	788
Total Gross Profit	7,053	7,777	7,872	6,805	4,609	4,358	5,165	3,603	2,619	2,284
Total Revenue	14,905	17,429	17,227	14,626	10,045	9,654	11,077	8,014	5,886	5,259
Operating Revenue	14,905	17,429	17,227	14,626	10,045	9,654	11,077	8,014	5,886	5,259
Total Cost of Revenue	7,853	9,652	9,355	7,821	5,436	5,295	5,912	4,410	3,267	2,975
Operating Cost of Revenue	7,809	9,652	9,355	7,821	5,436	5,295	5,912	4,410	3,267	2,975
Total Operating Expenses	2,789	2,602	2,490	2,323	1,935	1,894	1,952	1,701	1,545	1,496
Selling, General & Admin Expense	868	833	886	830	682	702	762	667	631	592
Research & Development Expense	1,902	1,727	1,604	1,493	1,252	1,191	1,190	1,034	914	825
Total Other Income / (Expense), net	96	-66	-189	-111	-99	-18	-62	-90	-114	-47
Other Income / (Expense), net	96	-66	-189	-111	-99	-18	-62	-90	-114	-47
Income Tax Expense	532	598	588	462	323	255	771	114	46	85
Basic Earnings per Share	$29.13	$33.30	$32.92	$27.22	$15.55	$14.37	$14.73	$10.47	$5.75	$4.11
Weighted Average Basic Shares Outstanding	131.41M	135.47M	139.90M	143.61M	144.81M	152.48M	161.64M	162.22M	158.92M	159.63M
Diluted Earnings per Share	$29.00	$33.21	$32.75	$26.90	$15.10	$13.70	$13.17	$9.24	$5.22	$3.70
Weighted Average Diluted Shares Outstanding	132.00M	135.83M	140.63M	145.32M	149.09M	159.92M	180.78M	183.77M	175.16M	177.07M
Weighted Average Basic & Diluted Shares Outstanding	129.88M	132.51M	136.99M	141.95M	145.63M	144.53M	161.60M	162.20M	159M	159.50M
Cash Dividends to Common per Share	$8.00	$6.90	$6.00	$5.20	$4.60	$4.40	$2.55	$1.65	$1.20	$0.84

This table shows Lam Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/24/2023	9/24/2023	6/25/2023	3/26/2023	12/25/2022	9/25/2022
Net Income / (Loss) Attributable to Common Shareholders	1,331	1,191	1,116	1,020	966	954	887	803	814	1,469	1,426
Consolidated Net Income / (Loss)	1,331	1,191	1,116	1,020	966	954	887	803	814	1,469	1,426
Net Income / (Loss) Continuing Operations	1,331	1,191	1,116	1,020	966	954	887	803	814	1,469	1,426
Total Pre-Tax Income	1,537	1,348	1,294	1,154	1,093	1,087	1,026	864	939	1,652	1,655
Total Operating Income	1,562	1,334	1,264	1,127	1,057	1,057	1,023	855	942	1,680	1,698
Total Gross Profit	2,314	2,073	2,003	1,840	1,801	1,757	1,655	1,458	1,606	2,376	2,337
Total Revenue	4,720	4,376	4,168	3,872	3,794	3,758	3,482	3,207	3,870	5,278	5,074
Operating Revenue	4,720	4,376	4,168	3,872	3,794	3,758	3,482	3,207	3,870	5,278	5,074
Total Cost of Revenue	2,406	2,303	2,165	2,031	1,993	2,001	1,827	1,749	2,264	2,901	2,737
Operating Cost of Revenue	2,406	2,303	2,165	2,011	1,993	1,986	1,819	1,749	2,264	2,901	2,737
Total Operating Expenses	752	739	738	714	743	700	632	604	663	696	639
Selling, General & Admin Expense	226	244	243	216	216	229	207	200	194	234	206
Research & Development Expense	526	495	495	498	512	470	423	402	429	462	433
Total Other Income / (Expense), net	-25	14	30	28	36	30	2.60	9.01	-3.33	-28	-43
Other Income / (Expense), net	-25	14	30	28	36	30	2.60	9.01	-3.33	-28	-43
Income Tax Expense	206	157	178	134	127	133	138	61	125	183	229
Basic Earnings per Share	$1.04	$0.93	$0.86	$7.81	$7.38	$0.72	$0.67	$6.05	$6.03	$10.80	$10.42
Weighted Average Basic Shares Outstanding	1.28B	1.29B	1.30B	131.41M	130.84M	1.32B	1.33B	135.47M	134.92M	136.02M	136.89M
Diluted Earnings per Share	$1.03	$0.92	$0.86	$7.78	$7.34	$0.72	$0.67	$6.04	$6.01	$10.77	$10.39
Weighted Average Diluted Shares Outstanding	1.29B	1.29B	1.30B	132.00M	131.52M	1.32B	1.33B	135.83M	135.40M	136.34M	137.21M
Weighted Average Basic & Diluted Shares Outstanding	1.28B	1.28B	1.29B	129.88M	130.74M	131.10M	131.79M	132.51M	134.34M	134.94M	136.38M
Cash Dividends to Common per Share	$0.23	$0.23	$0.23	-	$2.00	-	-	-	$1.73	$1.73	$1.73

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/25/2023	6/26/2022	6/27/2021	6/28/2020	6/30/2019	6/24/2018	6/25/2017	6/26/2016	6/28/2015
Net Change in Cash & Equivalents	263	1,814	-897	-498	1,256	-855	2,135	-2,656	3,811	831
Net Cash From Operating Activities	4,652	5,179	3,100	3,588	2,126	3,176	2,656	2,029	1,295	666
Net Cash From Continuing Operating Activities	4,652	5,179	3,100	3,588	2,126	3,176	2,656	2,029	1,295	666
Net Income / (Loss) Continuing Operations	3,828	4,511	4,605	3,908	2,252	2,191	2,381	1,698	914	656
Consolidated Net Income / (Loss)	3,828	4,511	4,605	3,908	2,252	2,191	2,381	1,698	914	656
Depreciation Expense	360	342	334	307	269	309	326	307	291	278
Non-Cash Adjustments To Reconcile Net Income	303	339	214	203	196	189	248	166	191	148
Changes in Operating Assets and Liabilities, net	161	-13	-2,054	-830	-590	487	-314	-167	-101	-415
Net Cash From Investing Activities	-371	-535	612	73	-244	-1,637	2,749	-2,053	469	-194
Net Cash From Continuing Investing Activities	-371	-535	612	73	-244	-1,637	2,749	-2,053	469	-194
Purchase of Property, Plant & Equipment	-397	-502	-546	-349	-203	-303	-273	-157	-175	-198
Acquisitions	0.00	-120	0.00	0.00	-	-	-116	0.00	-	-
Purchase of Investments	0.00	0.00	-568	-3,389	-2,898	-2,930	-2,533	-4,582	-	-
Sale and/or Maturity of Investments	38	98	1,734	3,854	2,883	1,604	5,686	2,698	643	-
Other Investing Activities, net	-12	-11	-7.58	-42	-26	-7.36	-15	-13	1.64	3.98
Net Cash From Financing Activities	-3,996	-2,831	-4,579	-4,167	-624	-2,390	-3,272	-2,632	2,048	369
Net Cash From Continuing Financing Activities	-3,996	-2,831	-4,579	-4,167	-624	-2,390	-3,272	-2,632	2,048	369
Repayment of Debt	-270	-27	-12	-864	-1,916	-493	-1,506	-1,688	-0.49	-0.66
Repurchase of Common Equity	-2,843	-2,017	-3,866	-2,698	-1,370	-3,781	-2,653	-812	-158	-573
Payment of Dividends	-1,019	-908	-815	-727	-657	-678	-308	-243	-190	-116
Issuance of Common Equity	136	121	114	122	94	85	85	73	59	66
Effect of Exchange Rate Changes	-22	0.13	-30	7.22	-2.75	-4.04	2.59	-0.06	-0.72	-9.02
Cash Interest Paid	173	175	176	204	172	77	84	105	-	-
Cash Income Taxes Paid	992	810	808	519	223	300	143	28	40	115

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/24/2023	9/24/2023	6/25/2023	3/26/2023	12/25/2022	9/25/2022
Net Change in Cash & Equivalents	-214	-395	221	177	48	499	-461	31	820	229	734
Net Cash From Operating Activities	1,309	742	1,568	862	1,385	1,454	951	1,123	1,726	1,140	1,190
Net Cash From Continuing Operating Activities	1,309	742	1,568	862	1,385	1,454	951	1,123	1,726	1,140	1,190
Net Income / (Loss) Continuing Operations	1,331	1,191	1,116	1,020	966	954	887	803	814	1,469	1,426
Consolidated Net Income / (Loss)	1,331	1,191	1,116	1,020	966	954	887	803	814	1,469	1,426
Depreciation Expense	97	96	94	88	90	91	90	90	92	85	76
Non-Cash Adjustments To Reconcile Net Income	89	73	80	75	87	74	67	242	-58	86	68
Changes in Operating Assets and Liabilities, net	-208	-619	278	-321	242	335	-94	-12	878	-500	-380
Net Cash From Investing Activities	-293	-175	-111	-102	-92	-102	-75	-55	-84	-267	-128
Net Cash From Continuing Investing Activities	-293	-175	-111	-102	-92	-102	-75	-55	-84	-267	-128
Purchase of Property, Plant & Equipment	-288	-188	-111	-101	-104	-115	-77	-79	-119	-163	-140
Other Investing Activities, net	-4.86	13	0.04	-0.87	-3.36	-2.52	-4.97	-2.79	-4.29	-1.66	-2.44
Net Cash From Financing Activities	-1,233	-935	-1,259	-574	-1,236	-860	-1,326	-1,038	-820	-662	-311
Net Cash From Continuing Financing Activities	-1,233	-935	-1,259	-574	-1,236	-860	-1,326	-1,038	-820	-662	-311
Repayment of Debt	-504	-0.27	-1.26	-8.82	-0.76	-4.81	-255	-4.98	-3.61	-16	-2.34
Repurchase of Common Equity	-435	-698	-997	-374	-981	-645	-843	-869	-582	-456	-110
Payment of Dividends	-296	-298	-261	-261	-263	-264	-230	-232	-234	-236	-206
Issuance of Common Equity	1.99	60	-0.04	70	8.24	55	2.82	68	-	46	6.80
Effect of Exchange Rate Changes	2.38	-26	23	-9.62	-8.45	6.73	-11	1.48	-2.30	18	-17

This table presents Lam Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/25/2023	6/26/2022	6/27/2021	6/28/2020	6/30/2019	6/24/2018	6/25/2017	6/26/2016	6/28/2015
Total Assets	18,745	18,782	17,196	15,892	14,559	12,001	12,479	12,123	12,264	9,365
Total Current Assets	12,883	13,228	12,285	11,652	10,854	8,560	9,150	9,142	9,213	6,271
Cash & Equivalents	5,848	5,337	3,522	4,418	4,915	3,658	4,512	2,378	5,039	1,502
Accounts Receivable	2,519	2,823	4,314	3,026	2,097	1,456	2,177	1,673	1,262	1,094
Inventories, net	4,218	4,816	3,966	2,689	1,900	1,540	1,876	1,233	972	943
Prepaid Expenses	298	252	347	208	146	134	147	195	151	157
Plant, Property, & Equipment, net	2,155	1,857	1,648	0.00	0.00	0.00	903	686	640	621
Total Noncurrent Assets	3,707	3,697	3,263	4,240	3,706	3,441	2,427	2,295	2,412	2,472
Goodwill	1,765	1,622	1,515	1,490	1,484	1,485	1,485	1,386	1,386	1,388
Other Noncurrent Operating Assets	1,942	1,906	1,394	2,365	1,799	1,484	368	242	210	186
Total Liabilities & Shareholders' Equity	18,745	18,782	17,196	15,892	14,559	12,001	12,479	12,123	12,264	9,365
Total Liabilities	10,205	10,571	10,917	9,865	9,376	7,278	5,899	5,135	6,162	4,020
Total Current Liabilities	4,338	4,185	4,565	3,528	3,162	2,372	3,150	2,950	2,418	2,631
Short-Term Debt	505	8.36	7.38	11	840	667	610	908	948	1,360
Accounts Payable	614	471	1,011	830	592	377	511	465	348	300
Accrued Expenses	1,802	2,011	1,974	1,719	1,273	947	1,309	969	773	649
Current Deferred Revenue	1,418	1,695	-	967	458	381	720	608	349	322
Total Noncurrent Liabilities	5,867	6,387	6,353	6,337	6,213	4,906	2,749	2,185	3,744	1,388
Long-Term Debt	4,479	5,003	4,998	4,990	4,971	3,823	1,807	1,785	3,378	1,001
Noncurrent Deferred Revenue	813	882	931	948	910	893	852	120	232	203
Other Noncurrent Operating Liabilities	575	501	423	399	333	191	91	280	135	184
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	8,539	8,210	6,278	6,027	5,172	4,674	6,502	6,817	5,895	5,103
Total Preferred & Common Equity	8,539	8,210	6,278	6,027	5,172	4,674	6,502	6,817	5,895	5,103
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	8,539	8,210	6,278	6,027	5,172	4,674	6,502	6,817	5,895	5,103
Common Stock	8,224	7,809	7,415	7,053	6,696	6,410	6,145	5,846	5,573	5,367
Retained Earnings	24,811	22,032	18,455	14,685	11,521	9,931	8,261	6,250	4,820	4,097
Treasury Stock	-24,366	-21,530	-19,481	-15,647	-12,950	-11,603	-7,846	-5,216	-4,429	-4,303
Accumulated Other Comprehensive Income / (Loss)	-130	-101	-110	-64	-94	-64	-57	-62	-69	-58

This table presents Lam Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/24/2023	9/24/2023	6/25/2023	3/26/2023	12/25/2022	9/25/2022
Total Assets	19,968	19,840	19,532	18,745	18,280	18,784	18,538	18,782	19,243	19,206	18,721
Total Current Assets	13,460	13,613	13,492	12,883	12,488	13,055	12,994	13,228	13,730	13,709	13,613
Cash & Equivalents	5,451	5,665	6,067	5,848	5,672	5,623	5,126	5,337	5,306	4,485	4,256
Accounts Receivable	3,228	3,305	2,937	2,519	2,204	2,707	2,811	2,823	3,262	4,070	4,570
Inventories, net	4,463	4,358	4,210	4,218	4,323	4,430	4,748	4,816	4,882	4,820	4,360
Prepaid Expenses	318	284	278	298	290	279	278	252	216	231	306
Plant, Property, & Equipment, net	2,372	2,314	2,214	2,155	2,182	2,147	2,111	1,857	0.00	0.00	1,719
Total Noncurrent Assets	4,136	3,913	3,826	3,707	3,609	3,582	3,434	3,697	5,513	5,498	3,390
Goodwill	1,795	1,761	1,758	1,765	1,627	1,627	1,626	1,622	1,622	1,620	1,515
Other Noncurrent Operating Assets	2,341	2,152	2,068	1,942	1,840	1,804	1,650	1,906	3,461	3,441	1,514
Total Liabilities & Shareholders' Equity	19,968	19,840	19,532	18,745	18,280	18,784	18,538	18,782	19,243	19,206	18,721
Total Liabilities	10,457	11,032	11,061	10,205	10,258	10,561	10,491	10,571	10,836	10,902	11,309
Total Current Liabilities	5,490	5,350	5,343	4,338	4,430	4,272	4,247	4,185	4,441	4,547	5,053
Short-Term Debt	754	504	505	505	505	3.78	3.86	8.36	8.46	7.23	7.11
Accounts Payable	853	822	704	614	532	500	528	471	602	919	1,146
Accrued Expenses	2,000	2,096	2,196	1,802	1,792	1,976	2,120	2,011	1,990	2,068	1,949
Current Deferred Revenue	1,882	-	1,937	1,418	1,602	-	1,595	1,695	1,841	1,552	1,951
Total Noncurrent Liabilities	4,967	5,682	5,718	5,867	5,827	6,289	6,244	6,387	6,395	6,355	6,255
Long-Term Debt	3,730	4,478	4,479	4,479	4,478	4,980	4,980	5,003	4,997	4,996	4,996
Noncurrent Deferred Revenue	691	670	665	813	832	798	781	882	885	862	840
Other Noncurrent Operating Liabilities	547	534	574	575	517	511	483	501	512	496	419
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	9,511	8,808	8,472	8,539	8,022	8,222	8,047	8,210	8,407	8,305	7,413
Total Preferred & Common Equity	9,511	8,808	8,472	8,539	8,022	8,222	8,047	8,210	8,407	8,305	7,413
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	9,511	8,808	8,472	8,539	8,022	8,222	8,047	8,210	8,407	8,305	7,413
Common Stock	8,530	8,441	8,304	8,224	8,082	7,997	7,879	7,809	7,680	7,606	7,493
Retained Earnings	27,561	26,525	25,630	24,811	24,052	23,347	22,655	22,032	21,460	20,879	19,645
Treasury Stock	-26,456	-26,024	-25,375	-24,366	-23,985	-23,004	-22,366	-21,530	-20,628	-20,072	-19,591
Accumulated Other Comprehensive Income / (Loss)	-124	-134	-88	-130	-128	-118	-121	-101	-105	-109	-134

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/25/2023	6/26/2022	6/27/2021	6/28/2020	6/30/2019	6/24/2018	6/25/2017	6/26/2016	6/28/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.48%	1.17%	17.78%	45.61%	4.05%	-12.85%	38.23%	36.15%	11.91%	14.15%
EBITDA Growth	-13.42%	-1.36%	18.15%	64.51%	3.18%	-21.09%	62.91%	71.35%	22.81%	0.31%
EBIT Growth	-14.66%	-1.62%	18.81%	69.74%	5.25%	-22.38%	73.97%	88.69%	29.60%	2.42%
NOPAT Growth	-18.07%	-4.27%	19.08%	71.41%	5.91%	-9.04%	36.16%	74.29%	46.66%	17.72%
Net Income Growth	-15.14%	-2.05%	17.83%	73.57%	2.75%	-7.95%	40.22%	85.74%	39.43%	3.68%
EPS Growth	-12.68%	1.40%	21.75%	78.15%	10.22%	4.02%	42.53%	77.01%	41.08%	2.21%
Operating Cash Flow Growth	-10.17%	67.08%	-13.61%	68.74%	-33.05%	19.59%	30.87%	56.70%	94.38%	-11.54%
Free Cash Flow Firm Growth	-2.62%	66.02%	-18.25%	62.99%	-25.76%	22.37%	15.50%	54.53%	96.74%	0.58%
Invested Capital Growth	-2.66%	6.91%	46.12%	25.24%	14.27%	-6.96%	12.04%	1.01%	-3.15%	3.66%
Revenue Q/Q Growth	4.66%	-7.57%	2.93%	10.20%	4.48%	-7.34%	7.59%	11.07%	1.11%	4.63%
EBITDA Q/Q Growth	6.53%	-8.30%	1.09%	13.82%	5.35%	-11.96%	11.34%	19.57%	10.23%	-10.52%
EBIT Q/Q Growth	7.14%	-8.84%	0.98%	14.71%	5.70%	-12.48%	12.68%	21.57%	13.11%	-13.82%
NOPAT Q/Q Growth	5.70%	-10.21%	3.58%	12.52%	7.15%	-17.56%	25.60%	15.83%	15.46%	-2.67%
Net Income Q/Q Growth	6.03%	-8.26%	1.42%	12.95%	7.38%	-17.95%	26.23%	18.70%	16.23%	-13.48%
EPS Q/Q Growth	6.38%	-7.52%	2.50%	13.69%	8.71%	-13.84%	27.37%	17.86%	16.00%	-12.94%
Operating Cash Flow Q/Q Growth	-5.30%	15.08%	-24.24%	21.01%	-3.07%	5.38%	-1.75%	30.34%	57.34%	-40.88%
Free Cash Flow Firm Q/Q Growth	-1.19%	8.97%	-26.52%	24.56%	-4.37%	7.44%	-1.43%	11.70%	24.23%	-7.48%
Invested Capital Q/Q Growth	4.66%	1.18%	14.71%	-1.98%	1.05%	-5.32%	13.24%	-2.33%	-4.05%	-1.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.32%	44.62%	45.69%	46.53%	45.88%	45.15%	46.63%	44.97%	44.49%	43.43%
EBITDA Margin	31.67%	31.28%	32.08%	31.98%	28.31%	28.55%	31.53%	26.75%	21.26%	19.37%
Operating Margin	28.61%	29.69%	31.24%	30.64%	26.62%	25.53%	29.01%	23.74%	18.25%	14.98%
EBIT Margin	29.25%	29.32%	30.15%	29.88%	25.64%	25.34%	28.45%	22.61%	16.31%	14.09%
Profit (Net Income) Margin	25.68%	25.88%	26.73%	26.72%	22.42%	22.70%	21.49%	21.19%	15.53%	12.47%
Tax Burden Percent	87.79%	88.29%	88.68%	89.42%	87.45%	89.57%	75.53%	93.71%	95.20%	88.49%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	12.21%	11.71%	11.32%	10.58%	12.55%	10.43%	24.47%	6.29%	4.80%	11.51%
Return on Invested Capital (ROIC)	48.11%	59.88%	76.84%	88.31%	61.88%	60.34%	67.66%	52.95%	30.04%	20.53%
ROIC Less NNEP Spread (ROIC-NNEP)	33.91%	44.85%	-210.15%	97.63%	69.24%	61.16%	69.12%	55.62%	34.73%	22.74%
Return on Net Nonoperating Assets (RNNOA)	-2.41%	2.39%	-1.99%	-18.58%	-16.42%	-21.56%	-32.57%	-27.01%	-14.07%	-8.11%
Return on Equity (ROE)	45.71%	62.27%	74.85%	69.73%	45.46%	38.77%	35.09%	25.94%	15.97%	12.42%
Cash Return on Invested Capital (CROIC)	50.81%	53.20%	39.36%	65.89%	48.56%	67.55%	56.31%	51.95%	33.24%	16.93%
Operating Return on Assets (OROA)	23.24%	28.40%	31.39%	28.71%	19.39%	19.99%	25.62%	14.86%	8.88%	8.54%
Return on Assets (ROA)	20.40%	25.08%	27.84%	25.67%	16.96%	17.90%	19.35%	13.92%	8.45%	7.55%
Return on Common Equity (ROCE)	45.71%	62.27%	74.85%	69.66%	45.18%	38.34%	34.45%	25.19%	15.34%	11.92%
Return on Equity Simple (ROE_SIMPLE)	44.82%	54.94%	73.35%	64.85%	43.53%	46.89%	36.62%	24.90%	15.51%	12.85%
Net Operating Profit after Tax (NOPAT)	3,743	4,569	4,773	4,008	2,338	2,208	2,427	1,783	1,023	697
NOPAT Margin	25.11%	26.22%	27.70%	27.40%	23.28%	22.87%	21.91%	22.24%	17.38%	13.26%
Net Nonoperating Expense Percent (NNEP)	14.21%	15.03%	286.99%	-9.32%	-7.36%	-0.82%	-1.45%	-2.67%	-4.68%	-2.22%
Cost of Revenue to Revenue	52.68%	55.38%	54.31%	53.47%	54.12%	54.85%	53.37%	55.03%	55.51%	56.57%
SG&A Expenses to Revenue	5.83%	4.78%	5.14%	5.67%	6.79%	7.28%	6.88%	8.33%	10.72%	11.25%
R&D to Revenue	12.76%	9.91%	9.31%	10.21%	12.47%	12.34%	10.74%	12.90%	15.52%	15.69%
Operating Expenses to Revenue	18.71%	14.93%	14.45%	15.88%	19.26%	19.62%	17.62%	21.23%	26.24%	28.45%
Earnings before Interest and Taxes (EBIT)	4,360	5,109	5,193	4,371	2,575	2,447	3,152	1,812	960	741
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,720	5,452	5,527	4,678	2,844	2,756	3,493	2,144	1,251	1,019
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	16.30	9.86	9.71	14.41	8.11	5.65	4.03	3.24	1.98	2.25
Price to Tangible Book Value (P/TBV)	20.55	12.62	13.08	19.71	11.92	8.88	5.57	4.39	2.96	3.84
Price to Revenue (P/Rev)	9.34	4.65	3.54	5.94	4.18	2.73	2.36	2.75	1.98	2.18
Price to Earnings (P/E)	36.37	17.95	13.24	22.22	18.63	12.04	10.99	13.00	12.76	17.50
Dividend Yield	0.75%	1.14%	1.36%	0.85%	1.59%	2.50%	1.60%	1.21%	1.64%	1.16%
Earnings Yield	2.75%	5.57%	7.55%	4.50%	5.37%	8.30%	9.10%	7.69%	7.83%	5.71%
Enterprise Value to Invested Capital (EV/IC)	18.03	10.23	8.42	17.01	10.13	7.16	6.19	5.51	2.72	2.84
Enterprise Value to Revenue (EV/Rev)	9.28	4.63	3.60	5.87	4.06	2.61	2.12	2.32	1.55	1.87
Enterprise Value to EBITDA (EV/EBITDA)	29.31	14.80	11.23	18.35	14.35	9.16	6.72	8.69	7.29	9.65
Enterprise Value to EBIT (EV/EBIT)	31.73	15.79	11.95	19.64	15.85	10.32	7.44	10.28	9.50	13.27
Enterprise Value to NOPAT (EV/NOPAT)	36.96	17.65	13.01	21.42	17.45	11.43	9.67	10.45	8.92	14.09
Enterprise Value to Operating Cash Flow (EV/OCF)	29.74	15.57	20.03	23.93	19.19	7.95	8.83	9.18	7.04	14.75
Enterprise Value to Free Cash Flow (EV/FCFF)	35.00	19.87	25.39	28.70	22.24	10.21	11.62	10.65	8.06	17.09
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.58	0.61	0.80	0.83	1.12	0.95	0.37	0.39	0.71	0.44
Long-Term Debt to Equity	0.52	0.61	0.80	0.83	0.96	0.81	0.27	0.26	0.55	0.19
Financial Leverage	-0.07	0.05	0.01	-0.19	-0.24	-0.35	-0.47	-0.49	-0.41	-0.36
Leverage Ratio	2.24	2.48	2.69	2.72	2.68	2.17	1.81	1.86	1.89	1.64
Compound Leverage Factor	2.24	2.48	2.69	2.72	2.68	2.17	1.81	1.86	1.89	1.64
Debt to Total Capital	36.85%	37.90%	44.36%	45.35%	52.85%	48.73%	26.86%	27.82%	41.48%	30.64%
Short-Term Debt to Total Capital	3.73%	0.06%	0.07%	0.10%	7.64%	7.24%	6.78%	9.38%	9.09%	17.64%
Long-Term Debt to Total Capital	33.12%	37.84%	44.30%	45.25%	45.21%	41.49%	20.08%	18.44%	32.40%	12.99%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.10%	0.54%	0.87%	1.75%	1.99%	3.14%
Common Equity to Total Capital	63.15%	62.10%	55.64%	54.65%	47.05%	50.73%	72.27%	70.42%	56.53%	66.22%
Debt to EBITDA	1.06	0.92	0.91	1.07	2.04	1.63	0.69	1.26	3.46	2.32
Net Debt to EBITDA	-0.18	-0.06	0.20	-0.21	-0.41	-0.43	-0.80	-1.68	-2.20	-1.85
Long-Term Debt to EBITDA	0.95	0.92	0.90	1.07	1.75	1.39	0.52	0.83	2.70	0.98
Debt to NOPAT	1.33	1.10	1.05	1.25	2.49	2.03	1.00	1.51	4.23	3.39
Net Debt to NOPAT	-0.23	-0.07	0.23	-0.24	-0.49	-0.54	-1.15	-2.02	-2.69	-2.71
Long-Term Debt to NOPAT	1.20	1.10	1.05	1.25	2.13	1.73	0.74	1.00	3.30	1.44
Altman Z-Score	12.15	8.64	7.39	9.02	5.70	5.43	5.89	5.07	3.09	3.61
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.10%	0.61%	1.13%	1.83%	2.88%	3.93%	4.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.97	3.16	2.69	3.30	3.43	3.61	2.90	3.10	3.81	2.38
Quick Ratio	1.93	1.95	1.75	2.48	2.79	2.90	2.26	2.62	3.35	1.96
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,953	4,059	2,445	2,991	1,835	2,472	2,020	1,749	1,132	575
Operating Cash Flow to CapEx	1,172.83%	1,032.55%	567.67%	1,027.84%	1,046.28%	1,046.49%	971.13%	1,299.76%	738.60%	336.02%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.79	0.97	1.04	0.96	0.76	0.79	0.90	0.66	0.54	0.61
Accounts Receivable Turnover	5.58	4.88	4.69	5.71	5.65	5.32	5.75	5.46	5.00	5.55
Inventory Turnover	1.74	2.20	2.81	3.41	3.16	3.10	3.80	4.00	3.41	3.53
Fixed Asset Turnover	7.43	9.95	0.00	0.00	0.00	0.00	13.95	12.09	9.34	9.03
Accounts Payable Turnover	14.48	13.03	10.16	11.00	11.22	11.93	12.12	10.85	10.08	11.36
Days Sales Outstanding (DSO)	65.41	74.74	77.76	63.93	64.55	68.67	63.44	66.85	73.04	65.73
Days Inventory Outstanding (DIO)	209.96	166.07	129.84	107.09	115.49	117.75	95.98	91.24	106.99	103.30
Days Payable Outstanding (DPO)	25.21	28.02	35.91	33.18	32.53	30.59	30.12	33.64	36.22	32.13
Cash Conversion Cycle (CCC)	250.17	212.78	171.68	137.84	147.51	155.83	129.30	124.45	143.81	136.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,675	7,885	7,375	5,047	4,030	3,527	3,791	3,383	3,350	3,459
Invested Capital Turnover	1.92	2.28	2.77	3.22	2.66	2.64	3.09	2.38	1.73	1.55
Increase / (Decrease) in Invested Capital	-210	510	2,328	1,017	503	-264	407	34	-109	122
Enterprise Value (EV)	138,355	80,661	62,081	85,847	40,807	25,242	23,463	18,631	9,122	9,829
Market Capitalization	139,220	80,987	60,984	86,827	41,949	26,389	26,174	22,065	11,667	11,473
Book Value per Share	$65.32	$61.11	$45.26	$42.26	$35.63	$31.17	$39.63	$42.26	$36.93	$32.23
Tangible Book Value per Share	$51.82	$47.78	$33.60	$30.88	$24.25	$19.83	$28.65	$31.12	$24.71	$18.87
Total Capital	13,523	13,222	11,284	11,029	10,994	9,213	8,997	9,681	10,428	7,706
Total Debt	4,983	5,012	5,006	5,002	5,811	4,490	2,417	2,693	4,326	2,361
Total Long-Term Debt	4,479	5,003	4,998	4,990	4,971	3,823	1,807	1,785	3,378	1,001
Net Debt	-865	-326	1,097	-980	-1,153	-1,196	-2,789	-3,604	-2,752	-1,886
Capital Expenditures (CapEx)	397	502	546	349	203	303	273	156	175	198
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,202	3,715	4,070	2,407	1,821	1,425	1,660	1,060	915	923
Debt-free Net Working Capital (DFNWC)	9,050	9,052	7,728	8,136	8,531	6,856	6,610	7,101	7,743	4,999
Net Working Capital (NWC)	8,545	9,043	7,720	8,125	7,691	6,189	6,000	6,192	6,795	3,639
Net Nonoperating Expense (NNE)	-85	58	167	99	86	16	46	85	109	42
Net Nonoperating Obligations (NNO)	-865	-326	1,097	-980	-1,153	-1,196	-2,789	-3,604	-2,752	-1,886
Total Depreciation and Amortization (D&A)	360	342	334	307	269	309	341	332	291	278
Debt-free, Cash-free Net Working Capital to Revenue	21.48%	21.31%	23.63%	16.46%	18.13%	14.76%	14.99%	13.22%	15.54%	17.54%
Debt-free Net Working Capital to Revenue	60.71%	51.94%	44.86%	55.63%	84.93%	71.02%	59.67%	88.61%	131.55%	95.05%
Net Working Capital to Revenue	57.33%	51.89%	44.82%	55.55%	76.57%	64.11%	54.16%	77.27%	115.45%	69.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$29.13	$33.30	$32.92	$27.22	$15.55	$14.37	$14.73	$10.47	$5.75	$4.11
Adjusted Weighted Average Basic Shares Outstanding	131.41M	135.47M	139.90M	143.61M	144.81M	152.48M	161.64M	162.22M	158.92M	159.63M
Adjusted Diluted Earnings per Share	$29.00	$33.21	$32.75	$26.90	$15.10	$13.70	$13.17	$9.24	$5.22	$3.70
Adjusted Weighted Average Diluted Shares Outstanding	132.00M	135.83M	140.63M	145.32M	149.09M	159.92M	180.78M	183.77M	175.16M	177.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	129.88M	132.51M	136.99M	141.95M	145.63M	144.53M	157.58M	162.45M	160.26M	158.19M
Normalized Net Operating Profit after Tax (NOPAT)	3,743	4,606	4,773	4,008	2,338	2,208	2,427	1,783	1,023	768
Normalized NOPAT Margin	25.11%	26.43%	27.70%	27.40%	23.28%	22.87%	21.91%	22.24%	17.38%	14.60%
Pre Tax Income Margin	29.25%	29.32%	30.15%	29.88%	25.64%	25.34%	28.45%	22.61%	16.31%	14.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.62%	20.13%	17.70%	18.60%	29.17%	30.95%	12.92%	14.34%	20.83%	17.70%
Augmented Payout Ratio	100.89%	64.84%	101.64%	87.62%	90.00%	203.47%	124.37%	62.15%	38.16%	105.14%

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/24/2023	9/24/2023	6/25/2023	3/26/2023	12/25/2022	9/25/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	24.43%	16.44%	19.70%	20.71%	-1.96%	-28.79%	-31.38%	-30.81%	-4.70%	24.87%	17.88%
EBITDA Growth	38.12%	22.61%	24.41%	30.37%	14.80%	-32.20%	-35.50%	-34.12%	-15.45%	20.83%	21.59%
EBIT Growth	40.57%	24.02%	26.19%	33.67%	16.43%	-34.20%	-38.02%	-36.45%	-17.25%	21.81%	23.18%
NOPAT Growth	44.80%	26.97%	23.20%	25.38%	14.33%	-37.86%	-39.50%	-39.66%	-23.90%	26.69%	21.40%
Net Income Growth	37.78%	24.81%	25.81%	27.13%	18.65%	-35.02%	-37.76%	-33.62%	-20.33%	22.91%	20.86%
EPS Growth	41.10%	27.78%	25.81%	28.81%	22.13%	-35.02%	-37.76%	-30.89%	-17.67%	27.61%	25.63%
Operating Cash Flow Growth	-5.50%	-48.97%	64.90%	-23.18%	-19.79%	27.51%	-20.04%	152.90%	127.85%	-20.85%	160.01%
Free Cash Flow Firm Growth	-89.88%	-66.00%	97.59%	323.80%	354.85%	268.53%	314.17%	128.12%	-164.62%	-431.08%	8.08%
Invested Capital Growth	16.52%	7.36%	-6.18%	-2.66%	-5.89%	-10.63%	1.12%	6.91%	21.21%	43.78%	30.84%
Revenue Q/Q Growth	7.86%	4.99%	7.66%	2.05%	0.94%	7.93%	8.57%	-17.12%	-26.68%	4.01%	9.46%
EBITDA Q/Q Growth	13.14%	4.02%	11.74%	5.04%	0.43%	5.54%	17.09%	-7.51%	-40.68%	0.40%	19.61%
EBIT Q/Q Growth	13.99%	4.16%	12.12%	5.60%	0.56%	5.99%	18.76%	-8.02%	-43.16%	-0.17%	21.77%
NOPAT Q/Q Growth	14.76%	8.06%	9.52%	6.61%	0.63%	4.85%	11.46%	-2.78%	-45.31%	2.09%	11.16%
Net Income Q/Q Growth	11.73%	6.68%	9.43%	5.64%	1.21%	7.54%	10.57%	-1.41%	-44.57%	2.99%	17.95%
EPS Q/Q Growth	11.96%	6.98%	9.43%	5.99%	1.66%	7.54%	10.57%	0.50%	-44.20%	3.66%	18.88%
Operating Cash Flow Q/Q Growth	76.38%	-52.70%	81.87%	-37.72%	-4.75%	52.85%	-15.28%	-34.97%	51.42%	-4.15%	167.97%
Free Cash Flow Firm Q/Q Growth	-77.33%	-60.58%	30.84%	-13.48%	-23.81%	129.07%	180.64%	152.03%	49.62%	-191.11%	63.16%
Invested Capital Q/Q Growth	5.17%	9.97%	-3.74%	4.66%	-3.10%	-3.89%	-0.12%	1.18%	-7.98%	8.74%	5.60%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.02%	47.37%	48.05%	47.53%	47.46%	46.76%	47.52%	45.46%	41.49%	45.03%	46.05%
EBITDA Margin	34.62%	33.01%	33.32%	32.10%	31.19%	31.34%	32.05%	29.72%	26.63%	32.92%	34.10%
Operating Margin	33.09%	30.48%	30.33%	29.10%	27.87%	28.13%	29.38%	26.65%	24.35%	31.84%	33.46%
EBIT Margin	32.56%	30.81%	31.05%	29.82%	28.82%	28.92%	29.45%	26.93%	24.26%	31.30%	32.61%
Profit (Net Income) Margin	28.19%	27.22%	26.79%	26.35%	25.46%	25.39%	25.48%	25.02%	21.04%	27.83%	28.10%
Tax Burden Percent	86.59%	88.34%	86.26%	88.39%	88.35%	87.78%	86.52%	92.93%	86.70%	88.90%	86.17%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	13.41%	11.66%	13.74%	11.61%	11.65%	12.22%	13.48%	7.07%	13.30%	11.10%	13.83%
Return on Invested Capital (ROIC)	61.84%	55.63%	53.45%	49.28%	46.36%	44.09%	51.40%	56.56%	55.98%	75.09%	75.53%
ROIC Less NNEP Spread (ROIC-NNEP)	64.46%	53.74%	49.32%	45.15%	41.47%	33.40%	53.62%	58.73%	58.70%	86.99%	60.90%
Return on Net Nonoperating Assets (RNNOA)	-6.09%	-4.22%	-3.75%	-3.21%	-3.29%	-0.99%	0.70%	3.13%	-0.86%	-2.48%	2.34%
Return on Equity (ROE)	55.75%	51.41%	49.70%	46.07%	43.07%	43.10%	52.11%	59.69%	55.12%	72.60%	77.87%
Cash Return on Invested Capital (CROIC)	42.90%	46.41%	58.12%	50.81%	52.90%	53.94%	49.84%	53.20%	52.38%	38.54%	46.50%
Operating Return on Assets (OROA)	29.17%	25.86%	25.43%	23.69%	21.87%	21.80%	25.04%	26.09%	25.54%	33.22%	34.23%
Return on Assets (ROA)	25.26%	22.84%	21.94%	20.94%	19.33%	19.14%	21.66%	24.24%	22.14%	29.53%	29.50%
Return on Common Equity (ROCE)	55.75%	51.41%	49.70%	46.07%	43.07%	43.10%	52.11%	59.69%	55.12%	72.60%	77.87%
Return on Equity Simple (ROE_SIMPLE)	48.98%	48.75%	47.89%	0.00%	45.00%	42.06%	49.36%	0.00%	58.49%	61.71%	65.45%
Net Operating Profit after Tax (NOPAT)	1,352	1,178	1,090	996	934	928	885	794	817	1,494	1,463
NOPAT Margin	28.65%	26.93%	26.16%	25.72%	24.62%	24.69%	25.42%	24.76%	21.11%	28.30%	28.83%
Net Nonoperating Expense Percent (NNEP)	-2.62%	1.88%	4.13%	4.13%	4.89%	10.69%	-2.22%	-2.17%	-2.72%	-11.91%	14.63%
Return On Investment Capital (ROIC_SIMPLE)	9.66%	8.55%	-	-	-	7.03%	-	-	-	-	-
Cost of Revenue to Revenue	50.98%	52.63%	51.95%	52.47%	52.54%	53.24%	52.48%	54.54%	58.51%	54.97%	53.95%
SG&A Expenses to Revenue	4.79%	5.58%	5.83%	5.59%	5.69%	6.09%	5.95%	6.23%	5.00%	4.43%	4.05%
R&D to Revenue	11.14%	11.31%	11.88%	12.86%	13.50%	12.50%	12.14%	12.53%	11.10%	8.76%	8.54%
Operating Expenses to Revenue	15.93%	16.89%	17.72%	18.43%	19.60%	18.63%	18.14%	18.82%	17.14%	13.19%	12.59%
Earnings before Interest and Taxes (EBIT)	1,537	1,348	1,294	1,154	1,093	1,087	1,026	864	939	1,652	1,655
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,634	1,444	1,389	1,243	1,183	1,178	1,116	953	1,031	1,737	1,730
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.80	10.72	12.68	16.30	15.85	12.38	10.10	9.86	7.96	6.66	6.89
Price to Tangible Book Value (P/TBV)	12.08	13.40	16.00	20.55	20.33	15.79	12.97	12.62	10.13	8.51	8.83
Price to Revenue (P/Rev)	5.44	5.83	6.89	9.34	8.93	7.11	5.13	4.65	3.55	2.90	2.84
Price to Earnings (P/E)	20.01	22.00	26.48	36.37	35.22	29.43	20.45	17.95	13.61	10.79	10.53
Dividend Yield	1.23%	1.17%	1.00%	0.75%	0.80%	0.96%	1.17%	1.14%	1.35%	1.59%	2.07%
Earnings Yield	5.00%	4.55%	3.78%	2.75%	2.84%	3.40%	4.89%	5.57%	7.35%	9.27%	9.49%
Enterprise Value to Invested Capital (EV/IC)	10.80	11.54	14.39	18.03	17.24	13.36	10.29	10.23	8.51	6.55	6.61
Enterprise Value to Revenue (EV/Rev)	5.38	5.78	6.82	9.28	8.88	7.06	5.12	4.63	3.52	2.91	2.86
Enterprise Value to EBITDA (EV/EBITDA)	16.16	17.83	21.30	29.31	28.54	23.63	16.76	14.80	11.15	9.04	8.82
Enterprise Value to EBIT (EV/EBIT)	17.29	19.17	22.97	31.73	31.07	25.82	18.10	15.79	11.83	9.56	9.35
Enterprise Value to NOPAT (EV/NOPAT)	19.98	22.33	26.93	36.96	35.71	29.52	20.32	17.65	13.03	10.38	10.23
Enterprise Value to Operating Cash Flow (EV/OCF)	20.58	20.57	20.18	29.74	25.74	19.24	16.41	15.57	14.73	15.71	13.44
Enterprise Value to Free Cash Flow (EV/FCFF)	27.08	25.74	23.98	35.00	31.61	23.38	20.77	19.87	17.80	20.05	16.12
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.57	0.59	0.58	0.62	0.61	0.62	0.61	0.60	0.60	0.68
Long-Term Debt to Equity	0.39	0.51	0.53	0.52	0.56	0.61	0.62	0.61	0.59	0.60	0.67
Financial Leverage	-0.09	-0.08	-0.08	-0.07	-0.08	-0.03	0.01	0.05	-0.01	-0.03	0.04
Leverage Ratio	2.18	2.27	2.30	2.24	2.28	2.30	2.41	2.48	2.48	2.43	2.59
Compound Leverage Factor	2.18	2.27	2.30	2.24	2.28	2.30	2.41	2.48	2.48	2.43	2.59
Debt to Total Capital	32.04%	36.13%	37.04%	36.85%	38.32%	37.74%	38.25%	37.90%	37.32%	37.60%	40.30%
Short-Term Debt to Total Capital	5.39%	3.66%	3.75%	3.73%	3.88%	0.03%	0.03%	0.06%	0.06%	0.05%	0.06%
Long-Term Debt to Total Capital	26.65%	32.47%	33.29%	33.12%	34.43%	37.71%	38.22%	37.84%	37.26%	37.54%	40.24%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.96%	63.87%	62.96%	63.15%	61.68%	62.26%	61.75%	62.10%	62.68%	62.40%	59.70%
Debt to EBITDA	0.79	0.95	1.00	1.06	1.12	1.17	1.03	0.92	0.84	0.82	0.86
Net Debt to EBITDA	-0.17	-0.13	-0.22	-0.18	-0.16	-0.15	-0.04	-0.06	-0.10	0.03	0.06
Long-Term Debt to EBITDA	0.65	0.85	0.90	0.95	1.01	1.16	1.03	0.92	0.84	0.81	0.86
Debt to NOPAT	0.97	1.19	1.26	1.33	1.41	1.46	1.25	1.10	0.98	0.94	0.99
Net Debt to NOPAT	-0.21	-0.16	-0.27	-0.23	-0.19	-0.19	-0.04	-0.07	-0.12	0.03	0.07
Long-Term Debt to NOPAT	0.81	1.07	1.13	1.20	1.26	1.45	1.25	1.10	0.98	0.93	0.99
Altman Z-Score	8.87	8.55	9.18	11.58	10.78	9.04	7.96	7.90	6.99	6.41	5.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.45	2.54	2.53	2.97	2.82	3.06	3.06	3.16	3.09	3.02	2.69
Quick Ratio	1.58	1.68	1.69	1.93	1.78	1.95	1.88	1.95	1.94	1.90	1.77
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	141	622	1,577	1,205	1,393	1,829	798	284	-547	-1,085	-373
Operating Cash Flow to CapEx	454.31%	393.92%	1,418.30%	856.03%	1,336.02%	1,261.18%	1,235.41%	1,427.13%	1,445.24%	697.88%	849.32%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.90	0.84	0.82	0.79	0.76	0.75	0.85	0.97	1.05	1.06	1.05
Accounts Receivable Turnover	6.31	5.39	5.42	5.58	5.21	4.22	4.29	4.88	5.42	5.10	4.52
Inventory Turnover	2.03	1.93	1.83	1.74	1.64	1.70	1.92	2.20	2.50	2.64	2.70
Fixed Asset Turnover	7.53	7.27	7.21	7.43	0.00	0.00	8.27	9.95	0.00	0.00	0.00
Accounts Payable Turnover	12.86	12.85	13.29	14.48	13.36	11.05	10.44	13.03	12.97	11.13	9.84
Days Sales Outstanding (DSO)	57.85	67.69	67.28	65.41	70.04	86.39	85.06	74.74	67.40	71.60	80.79
Days Inventory Outstanding (DIO)	180.04	188.85	199.59	209.96	221.91	215.28	190.15	166.07	146.20	138.30	135.17
Days Payable Outstanding (DPO)	28.38	28.41	27.46	25.21	27.33	33.03	34.96	28.02	28.13	32.80	37.08
Cash Conversion Cycle (CCC)	209.51	228.13	239.42	250.17	264.62	268.65	240.25	212.78	185.47	177.10	178.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,545	8,125	7,388	7,675	7,333	7,568	7,875	7,885	7,793	8,469	7,788
Invested Capital Turnover	2.16	2.07	2.04	1.92	1.88	1.79	2.02	2.28	2.65	2.65	2.62
Increase / (Decrease) in Invested Capital	1,211	557	-487	-210	-459	-900	87	510	1,364	2,579	1,836
Enterprise Value (EV)	92,240	93,760	106,339	138,355	126,449	101,107	81,069	80,661	66,289	55,469	51,483
Market Capitalization	93,207	94,443	107,423	139,220	127,138	101,761	81,241	80,987	66,904	55,305	51,107
Book Value per Share	$7.41	$6.85	$65.23	$65.32	$61.19	$62.39	$60.73	$61.11	$62.31	$60.89	$54.11
Tangible Book Value per Share	$6.01	$5.48	$51.69	$51.82	$47.70	$48.90	$47.27	$47.78	$48.95	$47.66	$42.25
Total Capital	13,995	13,790	13,456	13,523	13,006	13,206	13,032	13,222	13,413	13,308	12,416
Total Debt	4,484	4,982	4,984	4,983	4,983	4,984	4,984	5,012	5,005	5,003	5,003
Total Long-Term Debt	3,730	4,478	4,479	4,479	4,478	4,980	4,980	5,003	4,997	4,996	4,996
Net Debt	-966	-683	-1,084	-865	-689	-654	-172	-326	-615	164	375
Capital Expenditures (CapEx)	288	188	111	101	104	115	77	79	119	163	140
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,274	3,101	2,587	3,202	2,891	3,148	3,594	3,715	3,928	4,581	4,189
Debt-free Net Working Capital (DFNWC)	8,725	8,767	8,654	9,050	8,563	8,786	8,750	9,052	9,297	9,169	8,566
Net Working Capital (NWC)	7,970	8,263	8,150	8,545	8,058	8,782	8,746	9,043	9,289	9,162	8,559
Net Nonoperating Expense (NNE)	22	-13	-26	-25	-32	-26	-2.25	-8.37	2.89	25	37
Net Nonoperating Obligations (NNO)	-966	-683	-1,084	-865	-689	-654	-172	-326	-615	164	375
Total Depreciation and Amortization (D&A)	97	96	94	88	90	91	90	90	92	85	76
Debt-free, Cash-free Net Working Capital to Revenue	19.11%	19.13%	16.59%	21.48%	20.30%	21.99%	22.69%	21.31%	20.83%	24.05%	23.28%
Debt-free Net Working Capital to Revenue	50.92%	54.09%	55.51%	60.71%	60.13%	61.37%	55.25%	51.94%	49.30%	48.14%	47.60%
Net Working Capital to Revenue	46.51%	50.97%	52.27%	57.33%	56.59%	61.34%	55.23%	51.89%	49.26%	48.10%	47.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.04	$0.93	$0.86	$7.81	$7.38	$0.73	$0.67	$6.05	$6.03	$10.80	$10.42
Adjusted Weighted Average Basic Shares Outstanding	1.28B	1.29B	1.30B	131.41M	130.84M	1.32B	1.33B	135.47M	134.92M	136.02M	136.89M
Adjusted Diluted Earnings per Share	$1.03	$0.92	$0.86	$7.78	$7.34	$0.72	$0.67	$6.04	$6.01	$10.77	$10.39
Adjusted Weighted Average Diluted Shares Outstanding	1.29B	1.29B	1.30B	132.00M	131.52M	1.32B	1.33B	135.83M	135.40M	136.34M	137.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.28B	1.28B	1.29B	129.88M	130.74M	1.31B	1.32B	132.51M	134.34M	134.94M	136.38M
Normalized Net Operating Profit after Tax (NOPAT)	1,352	1,178	1,090	996	947	928	885	794	852	1,494	1,463
Normalized NOPAT Margin	28.65%	26.93%	26.16%	25.72%	24.97%	24.69%	25.42%	24.76%	22.02%	28.30%	28.83%
Pre Tax Income Margin	32.56%	30.81%	31.05%	29.82%	28.82%	28.92%	29.45%	26.93%	24.26%	31.30%	32.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.95%	25.22%	25.87%	26.62%	27.42%	27.79%	23.48%	20.13%	17.97%	16.78%	17.22%
Augmented Payout Ratio	77.70%	96.23%	99.74%	100.89%	119.89%	112.80%	92.72%	64.84%	59.13%	71.03%	73.67%

Frequently Asked Questions About Lam Research's Financials

When does Lam Research's financial year end?

According to the most recent income statement we have on file, Lam Research's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has Lam Research's net income changed over the last 9 years?

Lam Research's net income appears to be on an upward trend, with a most recent value of $3.83 billion in 2024, rising from $655.58 million in 2015. The previous period was $4.51 billion in 2023. Check out Lam Research's forecast to explore projected trends and price targets.

What is Lam Research's operating income?

Lam Research's total operating income in 2024 was $4.26 billion, based on the following breakdown:

Total Gross Profit: $7.05 billion
Total Operating Expenses: $2.79 billion

How has Lam Research revenue changed over the last 9 years?

Over the last 9 years, Lam Research's total revenue changed from $5.26 billion in 2015 to $14.91 billion in 2024, a change of 183.4%.

How much debt does Lam Research have?

Lam Research's total liabilities were at $10.21 billion at the end of 2024, a 3.5% decrease from 2023, and a 153.9% increase since 2015.

How much cash does Lam Research have?

In the past 9 years, Lam Research's cash and equivalents has ranged from $1.50 billion in 2015 to $5.85 billion in 2024, and is currently $5.85 billion as of their latest financial filing in 2024.

How has Lam Research's book value per share changed over the last 9 years?

Over the last 9 years, Lam Research's book value per share changed from 32.23 in 2015 to 65.32 in 2024, a change of 102.6%.

Related Companies

This page (NASDAQ:LRCX) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lam Research (LRCX) Financials

Frequently Asked Questions About Lam Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lam Research (LRCX) Financials

Annual Income Statements for Lam Research

Quarterly Income Statements for Lam Research

Annual Cash Flow Statements for Lam Research

Quarterly Cash Flow Statements for Lam Research

Annual Balance Sheets for Lam Research

Quarterly Balance Sheets for Lam Research

Annual Metrics And Ratios for Lam Research

Quarterly Metrics And Ratios for Lam Research

Frequently Asked Questions About Lam Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools